Delivery Order SPE2DR25D3005-SPE2DR26FP7NN
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Trokendi XR 50 mg capsules (30-count package) with a ceiling value of $2,832.68. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The contract is performed at the company's corporate...
- The Defense Logistics Agency awarded a $5,386.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trokendi XR 200 mg capsules (30-count). This is a non-set-aside competitive award with an ultimate completion date of December 5, 2025, and represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) with a contract value of $3,085.77. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by September 18, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,403.67 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on July 11, 2025, with completion scheduled for July 14, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,180.32 to AmerisourceBergen Drug Corp for Trokendi XR 50 mg capsules (30-count) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) at a ceiling value of $2,459.90. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $25,401.53 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed-price contract type. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7NNDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,115.29 by the Defense Logistics Agency (DLA) on November 26, 2025, for the supply of Trokendi XR 200 mg capsules in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 28, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This specific delivery order for Trokendi XR—a medication used primarily for neurological and pain management applications—is one of numerous competitively awarded transactions the company fulfills through its prime indefinite delivery vehicle with DLA. The underlying IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/25/25 |